| Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development JG Meara, AJM Leather, L Hagander, BC Alkire, N Alonso, EA Ameh, ... The lancet 386 (9993), 569-624, 2015 | 4309 | 2015 |
| The burden of disease in older people and implications for health policy and practice MJ Prince, F Wu, Y Guo, LMG Robledo, M O'Donnell, R Sullivan, S Yusuf The lancet 385 (9967), 549-562, 2015 | 2449 | 2015 |
| The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study C Maringe, J Spicer, M Morris, A Purushotham, E Nolte, R Sullivan, ... The lancet oncology 21 (8), 1023-1034, 2020 | 1848 | 2020 |
| Economic burden of cancer across the European Union: a population-based cost analysis R Luengo-Fernandez, J Leal, A Gray, R Sullivan The lancet oncology 14 (12), 1165-1174, 2013 | 1297 | 2013 |
| Mortality due to cancer treatment delay: systematic review and meta-analysis TP Hanna, WD King, S Thibodeau, M Jalink, GA Paulin, E Harvey-Jones, ... bmj 371, 2020 | 1209 | 2020 |
| The global burden of women’s cancers: a grand challenge in global health O Ginsburg, F Bray, MP Coleman, V Vanderpuye, A Eniu, SR Kotha, ... The Lancet 389 (10071), 847-860, 2017 | 1179 | 2017 |
| A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical … NI Cherny, R Sullivan, U Dafni, JM Kerst, A Sobrero, C Zielinski, ... Annals of oncology 26 (8), 1547-1573, 2015 | 930 | 2015 |
| Delivering affordable cancer care in high-income countries R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ... The lancet oncology 12 (10), 933-980, 2011 | 827 | 2011 |
| Global cancer surgery: delivering safe, affordable, and timely cancer surgery R Sullivan, OI Alatise, BO Anderson, R Audisio, P Autier, A Aggarwal, ... The lancet oncology 16 (11), 1193-1224, 2015 | 686 | 2015 |
| Planning cancer control in Latin America and the Caribbean PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ... The lancet oncology 14 (5), 391-436, 2013 | 652 | 2013 |
| Medicinal mushrooms J Smith, N Rowan, R Sullivan Their therapeutic properties and current medical usage with special emphasis …, 2002 | 599* | 2002 |
| Challenges to effective cancer control in China, India, and Russia PE Goss, K Strasser-Weippl, BL Lee-Bychkovsky, L Fan, J Li, ... The lancet oncology 15 (5), 489-538, 2014 | 585 | 2014 |
| The growing burden of cancer in India: epidemiology and social context MK Mallath, DG Taylor, RA Badwe, GK Rath, V Shanta, CS Pramesh, ... The lancet oncology 15 (6), e205-e212, 2014 | 506 | 2014 |
| Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine R Sullivan, JE Smith, NJ Rowan Perspectives in biology and medicine 49 (2), 159-170, 2006 | 415 | 2006 |
| Economic burden of bladder cancer across the European Union J Leal, R Luengo-Fernandez, R Sullivan, JA Witjes European urology 69 (3), 438-447, 2016 | 363 | 2016 |
| Medicinal mushrooms: a rapidly developing area of biotechnology for cancer therapy and other bioactivities JE Smith, NJ Rowan, R Sullivan Biotechnology letters 24 (22), 1839-1845, 2002 | 324 | 2002 |
| Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer … AG Lai, L Pasea, A Banerjee, G Hall, S Denaxas, WH Chang, M Katsoulis, ... BMJ open 10 (11), e043828, 2020 | 308 | 2020 |
| Sustainable care for children with cancer: a Lancet Oncology Commission R Atun, N Bhakta, A Denburg, AL Frazier, P Friedrich, S Gupta, CG Lam, ... The Lancet Oncology 21 (4), e185-e224, 2020 | 291 | 2020 |
| The Lancet Commission on diagnostics: transforming access to diagnostics KA Fleming, S Horton, ML Wilson, R Atun, K DeStigter, J Flanigan, ... The Lancet 398 (10315), 1997-2050, 2021 | 290 | 2021 |
| Medicinal Mushrooms and Cancer JE Smith, NJ Rowan, R Sullivan | 284* | 2006 |
